Cargando…
Systemic chemotherapy with doxorubicin, cisplatin and capecitabine for metastatic hepatocellular carcinoma
BACKGROUND: Although numerous chemotherapeutic agents have been tested, the role of systemic chemotherapy for hepatocellular carcinoma (HCC) has not been clarified. New therapeutic strategies are thus needed to improve outcomes, and we designed this study with new effective drug combination. METHODS...
Autores principales: | Park, Se Hoon, Lee, Yuna, Han, Sang Hoon, Kwon, So Young, Kwon, Oh Sang, Kim, Sun Suk, Kim, Ju Hyun, Park, Yeon Ho, Lee, Jeong Nam, Bang, Soo-Mee, Cho, Eun Kyung, Shin, Dong Bok, Lee, Jae Hoon |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central,
2006
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1352374/ https://www.ncbi.nlm.nih.gov/pubmed/16396674 http://dx.doi.org/10.1186/1471-2407-6-3 |
Ejemplares similares
-
Thalidomide for Treating Metastatic Hepatocellular Carcinoma: A Pilot Study
por: Han, Sang Hoon, et al.
Publicado: (2006) -
Capecitabine in combination with either cisplatin or weekly paclitaxel as a first-line treatment for metastatic esophageal squamous cell carcinoma: a randomized phase II study
por: Lee, Su Jin, et al.
Publicado: (2015) -
Docetaxel plus cisplatin is effective for patients with metastatic breast cancer resistant to previous anthracycline treatment: a phase II clinical trial
por: Park, Se Hoon, et al.
Publicado: (2005) -
Epirubicin, cisplatin, and protracted venous infusion of 5-fluorouracil for advanced gastric carcinoma.
por: Cho, Eun Kyung, et al.
Publicado: (2002) -
Phase I trial of capecitabine plus everolimus (RAD001) in patients with previously treated metastatic gastric cancer
por: Lim, Taekyu, et al.
Publicado: (2011)